Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine versus placebo for cognitive control and error processing in healthy adults
ACTRN12615000093583Phase 4Recruiting
- Sponsor
- Professor Mark Bellgrove
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of clonidine in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Professor Mark Bellgrove. Primary endpoints: Mean stop signal reaction time, Number of errors on error awareness task and 1 more. Started Feb 2015; status: recruiting.
02
Drugs
clonidine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on ACTRN12615000093583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000093583.